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Received 11 December 2009; received in revised form 20 April 2010; accepted 21 April 2010Abstract Applications of differentiated progeny generated from human embryonic stem cells (hESCs) broadly span cell
replacement therapies and screening studies (toxicology, disease-drug modeling). These applications require differentiation
into lineage-specific cell types from hESCs that are largely dependent on several reported embryoid body (EB) formation
methods. However, methodologies for in vitro EB differentiation have not been quantitatively evaluated and compared.
Using the hematopoietic lineage as a test for differentiation competency, we performed multiparameter comparisons of
three prevalent EBmethods: (1) suspension (SP), (2) hanging drop (HD), and (3) forced aggregation (FA). Although FA improved
the homogeneity between hEBs, the highest hematopoietic induction efficiencies were observed in EBs formed in SP culture
independent of the presence or absence of serum. Despite the EB formation method used, EB-based hematopoietic
differentiation could be potently influenced by EB size and was augmented by paracrine signaling between cocultured EBs.
Our study identifies physical and physiological parameters contributing to the efficiency of hESC differentiation in EB formats
and reveals that EB methods are best tailored to specific applications unique to cell replacement vs small molecule screening
or early human development.
© 2010 Elsevier B.V. All rights reserved.Introduction
Humanembryonic stemcells (hESCs) are considered a valuable
and potentially unlimited resource for cell replacement
therapies (Murry & Keller, 2008) and in vitro screening for
disease-specific drug interactions and toxicity. Efficient
identification, isolation, and enrichment of target cells during
in vitro differentiation are critical if applications of hESC-
based derivatives are to be achieved. In the majority of cases,⁎ Corresponding author. McMaster Stem Cell and Cancer Research
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doi:10.1016/j.scr.2010.04.007effective differentiation requires clustering of cells into
embryoid bodies (EBs), and is best exemplified in recent
studies that have used procedures to enhance hematopoietic
differentiation (Vijayaragavan et al., 2009; Ng et al., 2005).
Recent reports have also indicated that sheer forces are potent
inducers of hematopoietic lineage development (Adamoet al.,
2009). This suggests that methods for EB formation are as
critical as the continued evaluation of candidate growth factor
regulators of lineage control from hESCs.
To date, differentiation from hESCs is induced by three
widely used hEB formation methods: (1) suspension (SP)
(Denning et al., 2006; Chadwick et al., 2003; Kaufman et al.,
2001), (2) hanging drop (HD) (Yoon et al., 2006), and (3) forced
aggregation (FA) (Ng et al., 2005; Burridge et al., 2007; Pick
et al., 2007; Ungrin et al., 2008). Both SP and HD methods
involve aggregates of hESC colonies while FA uses hESC.
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most widely used and provides a simple means to generate
hEBs. However, the resulting hEBs are highly heterogeneous in
both size and morphology (Denning et al., 2006; Kaufman et
al., 2001). This creates reproducibility issues between and/or
within experiments, thus complicating the use of hEBs for high-
throughput screening (Ungrin et al., 2008; Bauwens et al.,
2008; Peerani et al., 2007; Itskovitz-Eldor et al., 2000). Several
laboratories have developed EB formation methods for
specific lineages as well as protocols to reduce size heteroge-
neity (Ng et al., 2005; Yoon et al., 2006; Burridge et al., 2007;
Pick et al., 2007; Ungrin et al., 2008; Bauwens et al., 2008;
Peerani et al., 2007; Itskovitz-Eldor et al., 2000). Unfortu-
nately, EB differentiation methods available have not been
quantitatively evaluated and compared. This has made it
difficult to understand how various EB methods differ at the
level of physical and physiological parameters and how they
impact candidate growth factor evaluations toward gen-
erating lineage-specific cell types for various applications.
Here we evaluated hematopoietic differentiation from EBs
generated from hESCs under three different methods (SP, HD,
and FA) using multiple parameters including EB size, serum
supplementation, and paracrine effects. Our study establishes
morphological and functional criteria to predict the best
strategies for obtaining hESC derivatives for several applica-
tions that include appropriate yields for cell replacement
therapies and the consistency required for in vitro screening.Results
Methods used to form human EB formation influence
lineage-specific yield
To establish a platform for evaluating parameters regu-
lating hEB differentiation, we first optimized three different
hEB formation methods: the SP and HD methods using aggre-
gates and a FA method using defined numbers of single cells
from hESC cultures (Fig. 1A). FA methods have been previously
reported by several groups (Ng et al., 2005; Burridge et al.,
2007; Pick et al., 2007; Ungrin et al., 2008), and differences
existing among the protocols used in each study are sum-
marized and compared in Supplementary Table 1. The FA
protocol used here deviates from previous reports (Supplemen-
tary Table 1); however, the goal of the current study is
to compare three independent EB formationmethods to predict
the best strategies for basic and clinical applications of hESCs.
All hEBs were cultured for 15 days under established con-
ditions for hematopoietic differentiation containing 20% fetal
calf serum (FCS) or StemPro34 serum-free medium (Chadwick
et al., 2003) (Figs. 1B–D). Regardless of serum supplementa-
tion, hEBs formed by SP and HD methods were variable in
both morphology and size (Figs. 1B and C). However, FA-EBs
were uniform and displayed distinct morphology and growth
patterns attributed to culture dissociation followed by
reaggregation (Fig. 1D). Most FA-EBs grew in a round shape
with consistent cystic formation and even expansion. These
results demonstrate that the FA method used here yields hEBs
reproducible in both morphology and size.
Previous studies have focused on the generation of EBs
homogeneous in both size and morphology (Ng et al., 2005;
Burridge et al., 2007; Pick et al., 2007; Ungrin et al., 2008).Comparative evaluation of spatial distribution and varia-
tions between and/or within FA-EBs in parallel with tradi-
tional SP- and HD-EBs has not been conducted. Thus, we
examined the temporal and spatial expression patterns of
pluripotency (Oct4 and Sox2) and differentiation (PECAM-1)
markers. Similar frequencies of Oct4 between hEB formation
methods and reduction of Oct4 levels during differentiation
indicate that hEBs generated by each method efficiently
differentiated (Supplemental Figs. S1A and S1B). We
conducted whole-mount immunostaining on SP-, HD-, and
FA-EBs collected at Days 3 and 5 of hematopoietic differ-
entiation when Oct4 and Sox2 expressions were still
detectable (data not shown). Oct4 and Sox2 patterns were
irregular in SP- and HD-EBs, whereas expression was evenly
distributed and consistent between FA-EBs (Figs. 1E and F).
However, the frequency of positively stained hEBs was not
different between hEB generation methods (Figs. 1G and H).
This pattern was still maintained in hEBs at Day 5 of differ-
entiation, although staining intensity for Oct4 was weaker
than Day 3 (Figs. 1I–K). Interestingly, while the number of
SP- and HD-EBs with Oct4 and PECAM-1 positive signals at Day
5 of differentiation was decreased, most FA-EBs generated
using our methods were positive for Oct4 and PECAM-1 and
displayed more consistent staining patterns (Figs. 1L–N).
These results suggest that the superior uniformity of plur-
ipotency and differentiation marker expression and spatial
organization in FA-EBs may predict higher efficiency and yield
of target lineage cells.Formation of SP-EBs allows for highest yield of
hematopoietic cells
Ascellular transplantationofhESCderivatives is theprimarygoal
of regenerative medicine, the overall yield of lineage-specific
cells is critical. However, to date, quantitative analysis of actual
cell number has not been conducted, and most studies rely on
frequencyandnot efficiencyof cellular output (input of hESCs vs
output of mature lineages) (Ng et al., 2005; Yoon et al., 2006;
Burridge et al., 2007; Toh et al., 2007). Thus, we further
evaluated the impact of hEB methods on output of hematopoi-
etic cell number in the presence (20% FCS) and absence
(StemPro34 serum-free medium) of serum. As previously
characterized, hematopoietic development from hESCs can be
divided into two phases: hemogenic lineage specification phase
(Days 0–7) characterized by the appearance of the bipotent
hemogenic cells (CD45negPFV) with hematopoietic and endo-
thelial capacity followed by the commitment phase (Days 7–15)
characterized as the period in which committed hematopoietic
progenitors are detected (Vijayaragavan et al., 2009; Wang
et al., 2004). There was no significant difference in the
frequency of CD45negPFV cells or hematopoietic (CD45+CD34+
and CD45+) cells between hEB formation methods irrespective
of serum supplementation (Figs. 2A–C and Supplemental Figs.
S1C–S1E). hEBs culturedwith serumdisplayed an overall higher
frequency of CD45+CD34+ and CD45+ cells compared to those
inserum-freeconditions.Notably, the frequenciesofCD45+CD34+
and CD45+ cells were significantly increased in SP-EBs stimulated
by serum compared to SP-EBs cultured under serum-free condi-
tions at Day 15 (Figs. 2B and C). However, similar frequencies of
hemogenic and hematopoietic cells under both serum-containing
and serum-freeconditionswereobservedbyDay20 (Supplemental
Figure 1 Morphological and phenotypic observations in hEBs generated by SP, HD, and FA methods. (A) Schematic of hEB formation
methods using aggregates of hESC colonies and single cell suspensions. (B–D) Representative images of SP- (B), HD- (C), and FA-EBs (D).
hEBs were cultured under hematopoietic conditions for 15 days in the presence (black box) or absence (green box) of serum and analyzed.
(E and F) Whole-mount staining of Oct4 (E) and Sox2 (F) in hEBs formed by SP, HD, and FA methods at Day 3 of hematopoietic
differentiation. (G and H) Percentage of Oct4 (G) and Sox2 (H) positive hEBs at Day 3 of hematopoietic differentiation. (I–K) Costaining of
Oct4 and PECAM-1 was performed in SP-EB (I), HD-EB (J), and FA-EB (K) at Day 5 of hematopoietic differentiation. (L–N) Percentage of
Oct4, PECAM-1, and Oct4/PECAM-1 positive EBs shown in at Day 5 of hematopoietic differentiation. Scale bars, 500 µm.
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Figure 2 Comparisons of hematopoietic potential in SP-, HD-, and FA-EBs cultured in the presence or absence of serum. (A–C)
Percentage of CD45negPFV (A), CD45+CD34+ (B), and CD45+ (C) cells from dissociated SP-, HD-, and FA-EBs. (D) Total cell number of
differentiated hESCs. (E–G) Total number of CD45negPFV (E), CD45+CD34+ (F), and CD45+ (G) cells. hEBs were cultured in the
presence (black bars) or absence of serum (green bars). All bars indicate mean±SD from H1 and H9 cell lines. * Pb0.05; ** Pb0.01.
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differentiation on serum withdrawal. This suggests that lack of
serumdelaysbutdoesnot impair differentiation.Thus, serum-free
conditions make it possible to define the precise role of growth
factors during hEB differentiation.
Overall yield of lineage-specific cells from pluripotent
stem cells is mainly a product of total number of cells gener-
ated during a given differentiation protocol. The total number
of cells following 15 days of hEB differentiationwas significantly
increased in SP-EBs compared to both HD- and FA-EBs
independent of serum supplementation (Fig. 2D). Assessment
of hematopoietic output revealed that significantly more
CD45negPFV cells were generated in SP-EBs compared to HD-
and FA-EBs in the absence of serum (Fig. 2E). In contrast,
the total number of CD45+CD34+ and CD45+ cells was higher
in SP-EBs compared to all other hEB methods tested in the
presence of serum (Figs. 2F and G). These results demon-
strate that the highest yield of both precursor and committedhematopoietic cells was obtained using the SP-EBmethodology.
In addition, the presence of serum increased hematopoietic cell
numbers but inhibited total cell expansionwhen using the SP-EB
method. While our FA method produces more consistent hEB
morphology and size, the SP method is superior in generating
hematopoietic cells in terms of total yield, and may therefore
be better suited for differentiation assays prior to clinical
transplantation. Additionally, these results show that homoge-
neity in hEB morphology and phenotype is not an accurate
predictor of functional output or yield of tissue-specific cell
types, using the hematopoietic lineage as an example.SP-EBs produce the greatest number of hematopoietic
clonogenic progenitors
The colony forming unit (CFU) assay is commonly used to
evaluate multilineage hematopoietic progenitors with
124 S.-H. Hong et al.immense clonogenic proliferative capacity (Chadwick et
al., 2003; Wang et al., 2004). In parallel with the
phenotypic analysis above, we also conducted functional
CFU assays to compare multilineage hematopoietic pro-
genitor potential derived from SP-, HD-, and FA-EBs. Equal
cell numbers of dissociated EBs were plated and the
estimated number and phenotype of hematopoietic pro-
genitors were examined after 15 days. We observed CFU
colonies including CFU-G, CFU-M, CFU-GM, and CFU-E in
each group (Supplemental Fig. S3A). We also characterized
the phenotypes and hierarchical relationship of the
hematopoietic compartments derived from hESCs. In
order to compare clonogenic potentials between
cell populations within hEBs, we isolated specific subpopu-
lations based on the expression of hematopoietic lineage
markers such as CD34, CD45, CD43, and CD38.We found that
CD45+CD34+ cells produce the most CFU colonies com-
pared to other phenotypes (Supplemental Fig. S3B).
Therefore, we calculated the total number of hematopoi-
etic progenitors based on the frequency of CD45+CD34+
cells. Similar frequencies of CFU colonies were seen from
defined cell numbers (15 000 cells) of SP-, HD-, and FA-EBsFigure 3 Comparison of clonogenic capacity in SP-, HD-, and FA-EBs
progenitor capacity detected by plating 1.5×104 cells from dissociate
CFUs from dissociated SP-, HD-, and FA-EBs. (C) Distribution of CFU
erythroid (CFU-E), and bipotent colonies (CFU-GM). hEBs cultured in
seeded into methylcellulose. All bars indicate mean±SD from H1 andindependent of serum supplementation (Fig. 3A). The SP
method resulted in significantly higher total numbers of
hematopoietic progenitors compared to HD and FA regard-
less of serum presence (Fig. 3B). While no differences in
colony distribution were seen with each hEB generation
method, the production of CFU-E was significantly promot-
ed from EBs cultured under serum-free conditions (Fig. 3C).
These demonstrate that hEBs generated by SP, HD, and FA
methods possess similar functional potential; however, the
SP-EB method results in production of the greatest number
of total hematopoietic progenitors. Accordingly, our
analysis reveals that the SP-EB generation method is the
most appropriate for applications requiring high yields of
hematopoietic cells, such as in vivo transplantation studies
using hematopoietic cells.
Hematopoietic capacity is dependent on the
size of EBs
Previous studies have reported on differential EB size and
morphology generated by SP and HD methods and suggested a
relationship between EB size and differentiation capacity to acultured in the presence or absence of serum. (A) Hematopoietic
d SP-, HD-, and FA-EBs cultured for 15 days. (B) Total number of
subtypes including macrophage (CFU-M), granulocyte (CFU-G),
the presence (black bars) or absence of serum (green bars) were
H9 cell lines. * Pb0.05; ** Pb0.01.
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Peerani et al., 2007; Bader et al., 2001). To address this issue
during hematopoiesis, we examined the effect of EB size using
all three hEB formation methods available to the field. Fig. 4A
depicts hEB formation by SP and HD methods and grouping
depending on hEB size. hEB size measurements were taken
by averaging the longest and shortest diameter of selected
hEBs that were round shape, cystic, and nonfused. From these
measurements, SP-EBs and HD-EBs were divided into three
groups at Day 15 as follows: large (SP-L andHD-L, 1790±40 µm,
n=28), medium (SP-M and HD-M, 1100±30 µm, n=28), and
small size hEB (SP-S and HD-S, 570±30 µm, n=26). Individually
isolated and dissociated hEBswere analyzed by flow cytometryFigure 4 Relationship between hEB size and hematopoietic differe
measurement of hEB diameter, and flow cytometry at Day 15 of h
precursors (CD45negPFV; B and E), primitive hematopoietic cells (CD
from dissociated EBs cultured with hGFs. (H) Representative images
cells (20, 40, 60, and 80 K cells). Scale bars, 500 µm. (I) Percentage of
from 20, 40, 60, and 80 K cells. Efficiency of FA-EB formation (inset).
bars indicate mean±SD from H1 and H9 cell lines.to determine frequency of hematopoietic cells including
CD45negPFV, CD45+CD34+, and CD45+ cells at Day 15 of dif-
ferentiation (Figs. 4B–G and Supplemental Fig. S4). There
were no significant differences in the frequency of hemogenic
or hematopoietic cells generated between medium and large
size SP- or HD-EBs cultured with hGFs (Figs. 4B–G). However,
small SP- and HD-EBs generated significantly less CD45negPFV
(Figs. 4B and E), CD45+CD34+ (Figs. 4C and F), and CD45+ cells
(Figs. 4D and G) compared with medium and large hEBs, with
virtually no hematopoietic cells being generated in the small
hEBs (Table 1). In order to confirm the accuracy of individual
hEB analysis, in particular the small hEBs, we pooled large,
medium, and small hEBs, respectively, and testedntiation. (A) Schematic of hEB formation by SP and HD methods,
ematopoietic differentiation. (B–G) Percentage of hemogenic
45+CD34+; C and F), and committed blood cells (CD45+; D and G)
and diameter of FA-EBs formed using defined numbers of single
CD45negPFV, CD45+CD34+, and CD45+ cells in FA-EBs generated
L, large EB; M, medium EB; S, small EB. * Pb0.05; ** Pb0.01. All
Table 1 Comparison of hematopoietic differentiation between different size of EBs generated by SP and HD method
Hematopoietic differentiation (Day 15)
CD45negPFV CD45+CD34+ CD45+
% No. of EB % No. of EB % No. of EB
SP-L 18.8±3.6 (14) 10.6±1.9 (14) 20.8±3.2 (14)
SP-M 12.1±2.1 (14) 9.1±2.4 (14) 18.4±4.3 (14)
SP-S 5.6±1.7 (13) 1.2±0.7 (13) 2.6±1.6 (13)
HD-L 18.2±3.4 (14) 11.5±1.5 (14) 23.3±3.3 (14)
HD-M 20.5±2.9 (14) 10.3±3.4 (14) 15.8±5.1 (14)
HD-S 7.1±2.4 (13) 0.2±0.1 (13) 0.5±0.2 (13)
Analysis was performed in hEBs measured by averaging the longest and shortest diameter at Day 15 of hematopoietic differentiation. SP,
suspension; HD, hanging drop; L, large EB; M, medium EB; S, small EB.
126 S.-H. Hong et al.hematopoietic differentiation (Supplemental Fig. S5). We
obtained similar results as seen for individual hEB analysis.
These results indicate that hESC-derived hematopoietic
differentiation can be affected by smaller hEB size.
To evaluate the effect of EB size in a more reproducible
and homogeneous system, we then generated FA-EBs using
a defined number of single cells (20, 40, 60, and 80 K). These
hEBs were homogeneous in size and morphology (20 K, 460±
71 µm; 40 K, 520±55 µm; 60 K, 690±48 µm; 80 K, 830±108 µm)
(Fig. 4H). In contrast to the influence of size on SP- and HD-EBs,
input cell number had no effect on the emergence of
CD45negPFV cells in the FA-EBs (Fig. 4I). However, like SP-EBs
and HD-EBs, 80 K FA-EBs, which were equivalent in size to
“medium” SP- and HD-EBs, produced dramatically more CD45+
CD34+ and CD45+ cells compared to those from 60, 40, and 20 K
cells (approximately equivalent to “small” SP- and HD-EBs)
(Fig. 4I). Importantly, similar frequencies of hematopoiesis
were achieved using all EB generationmethods (comparing SP-M
and HD-M to FA-80 K), demonstrating that dissociation and
reaggregation do not negatively impact hEB developmental
potential. Together, these findings provide clear evidence
that hEB size, independent of hEB formation methods, pro-
foundly influences hematopoietic output resulting from hESC
differentiation and suggest that paracrine or autocrinemechan-
isms may be augmented with increased cell number.
Paracrine effects between EBs promote
hESC-derived hematopoiesis
During hEB differentiation, hEBs are generally cultured in
groups and not individually. However, it has not been deter-
mined whether cooperative paracrine interactions enhance
the production of hESC-derived cells. In our preliminary work,
we observed reduced hematopoiesis in single hEB culture
compared with group hEB culture (data not shown). This
observation, combined with the fact that larger EBs exhibit
increased hematopoiesis, prompted the hypothesis that
factors diluted in culture medium may be responsible for
effects on hematopoietic output. Accordingly, we examined
whether paracrine signaling between developing hEBs influ-
ences differentiation. To do this, we cultured SP-M and SP-L
hEBs for 15 days individually or in groups in StemPro34 serum-
free medium containing hGFs, or individually in the presence
of hEB conditioned media (CM) (Fig. 5A). All culture methods
producedmorphologically similar hEBs (Fig. 5B) that containedhemogenic and hematopoietic cells. There was no difference
in the frequency of CD45negPFV cells generated by group or
single culture (Fig. 5C). Surprisingly, grouping hEBs in culture
produced a significantly higher frequency of bothCD45+CD34+
and CD45+ cells compared to single hEB culture (Figs. 5D
and E). Culture of single hEBs in the presence of CM resulted
in a partial rescue in the frequency of CD45+CD34+ and CD45+
cells (Figs. 5D and E). These findings indicate that reduced
hematopoietic development in single hEB culture could be
compensated by secreted soluble factors in CM from concen-
trated hEBs. Thus, paracrine or autocrine effects in hEB cul-
ture system promote the production of hESC-derived
differentiated cells. Pragmatically, these results demon-
strate that caution should be exercised when defining optimal
growth factors cocktails for lineage control.
Discussion
Efficient generation of target cells or cell populations from
developing hEBs will be beneficial for clinical transplanta-
tion, high-throughput screening (new drugs and toxic mate-
rials), and identifying molecular pathways important for
lineage specification. Our analysis defines physical and
physiological criteria that predict functional output of dif-
ferentiated cells. While all hEB generation methods exhibit
similar hematopoietic potentials, differences in morphology
and cell numbers demonstrate that differentiation protocols
should be chosen based on the desired application. For
example, safety assessment of newly developed pharmaceu-
tical drugs should be achieved prior to the direct use in cell
replacement therapies. FA methods allow for reproducible
generation of homogeneous hEBs in terms of morphology,
size and growth making them more amenable to high-
throughput screening and drug discovery. In contrast, the HD
method, due to limited space of the hanging droplet, may be
more useful for the quantification of the auto- or paracrine
effects between specific cell populations rather than to
induce early lineage specification (Yoon et al., 2006;
Gutierrez et al., 2005). For transplantation studies, the SP
method is preferable for differentiating hESCs because of the
consistently higher yield of total number of cells for a given
lineage.
The SP method is the most common and easiest way to
generate hEBs and is achieved by scraping undifferentiated
hESC colonies after enzyme treatment. However, SP-EBs are
Figure 5 Paracrine interaction between hEBs augments the output of hematopoietic lineage cells. (A) Schematic of hEBs
cultured individually, in groups, and individually with conditioned medium (CM). CM was produced by collection of medium used
to feed hEBs cultured in groups. hEBs were cultured for 17 days supplemented with hGFs in StemPro34 serum-free medium and
the output of CD45negPFV, CD45+CD34+, and CD45+ cells was analyzed. (B) Representative images of developing hEBs. Scale bars,
500 µm. (C–E) Percentage of CD45negPFV (C), CD45+CD34+ (D), and CD45+ (E) cells from hEBs. All bars indicate mean±SD from H1
and H9 cell lines. *, Pb0.05.
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making it difficult to obtain reproducible results between and
evenwithin laboratories. Most studies have therefore focused
on the generation of homogeneous EBs in both size and
morphology (Ng et al., 2005; Burridge et al., 2007; Pick et al.,
2007). For example, Ungrin et al. (Ungrin et al., 2008)
reported that using single cells, spatially and temporally
synchronized hEBs could be generated that were suitable for
studying early human developmental processes. However,
other EB formation methods were not compared in this study.
To compare the yield of hematopoietic cells between EB
formation methods, we started with over 80% confluent
hESC cultures consisting of densely packed colonies and an
adequate ratio of undifferentiated to fibroblast-like cells
(Bendall et al., 2007). This starting criteria is critical for
obtaining an adequate total cell and hematopoietic cell yield
(Vijayaragavan et al., 2009; Chadwick et al., 2003; Wang
et al., 2004). However, the yield of hematopoietic cells was
significantly lower in our FA-EBs than SP- and HD-EBs. This
was attributed to the loss of single cells during FA-EB for-
mation and cellular damage during initial enzymatic disso-
ciation (Costa et al., 2007). To increase cell–cell adhesion
and cellular viability, FBS, polyvinyl alcohol, BSA, or ROCK
inhibitor may be added (Burridge et al., 2007; Watanabe
et al., 2007); however, exogenous reagents must be evalua-
ted for their potential adverse effects on lineage-specific
differentiation.Investigation into the influence of hEB size on differen-
tiation revealed that larger hEBs resulted in increased
frequencies of hematopoietic cells. This was clearly demon-
strated using FA-EBs, in which hEBs with b80 K cells
exhibited severely diminished hematopoietic potential.
While larger (1790±40 μm) hEBs were assessed for hemato-
poietic development, a point where EB size negatively im-
pacted differentiation could not be reached. Previous
studies have reported that there was an upper limit of EB
diameter during ESC differentiation, which could reduce the
overall yield of differentiated cells. Bader et al. (Bader
et al., 2001) monitored EBs with beating cardiomyocytes in
EBs made of different numbers of mouse ESC by the HD
method. They found that EBs generated from 565 single cells
could give rise to a maximum rate of beating cells. Con-
sistently, Burridge et al. (Burridge et al., 2007) showed that
the highest efficiency of cardiomyocyte differentiation
occurred when they transferred hEBs of 250–350 µm into
DMEM with 20% FBS. Recent investigation into micropattern-
ing of hESC culture revealed that differentiation trajectories
of hESCs could be controlled by engineering hESC composi-
tion and colony size (Bauwens et al., 2008; Peerani et al.,
2007; Lee et al., 2009). These findings were attributed to
the diffusion of soluble factors, both exogenous and endoge-
nous, into the EB for supply of nutrients and the status of the
input hESC composition. Therefore, an optimal number of
cells must be present to promote differentiation possibly
128 S.-H. Hong et al.through generation of a microenvironment that induces
dynamic signaling patterns.
To date, there are no reports evaluating the autocrine/
paracrine effects between hEBs during differentiation. We
observed that there are paracrine effects that improve
hematopoietic differentiation when there are multiple, as
opposed to single, hEBs in culture. This effect could also
be recapitulated using conditioned medium from concen-
trated hEB culture. Although we have not identified the
secreted factors that mediate these paracrine effects, our
study is the first to report the differences in differentiation
potential between grouped and single EB culture. The use of
serum-free conditions during hEB differentiation would
simplify analysis of the conditioned media to identify
potential soluble factors involved in hematopoietic
development.
In conclusion, our comparative multiparameter analysis
of the defining features contributing to hematopoietic
differentiation from hESCs reveals that: (1) the EB genera-
tion method, (2) serum supplementation, (3) EB size, and
(4) cooperative signals between hEBs govern functional
output. These parameters are likely not limited to the hema-
topoietic lineage of hESC derivatives. Therefore, our analysis
provides practical guidelines for selecting hEB formation
protocols tailored to specific goals within regenerative medi-
cine and stem cell-based applications.Materials and methods
hESC culture
Undifferentiated hESC lines H1 and H9 were maintained in
feeder-free culture as previously described (Chadwick
et al., 2003). Briefly, hESCs were cultured on Matrigel (BD
Biosciences, Bedford, MA, USA)-coated six-well plate with
mouse embryonic fibroblast-conditioned medium (MEF-CM)
supplemented with 8 ng/ml human recombinant basic
fibroblast growth factor (hbFGF; Invitrogen, Burlington,
ON, Canada). hESCs were fed daily with fresh MEF-CM and
were passaged at a 1:2 ratio every 6 or 7 days by enzymatic
dissociation with 200 U/ml collagenase IV (Invitrogen).
hEB formation
To generate hematopoietic cells from hESCs, we generated
hEBs by SP and HD culture methods as previously described
(Cerdan et al., 2007). Briefly, for SP culture, confluent
undifferentiated hESCs were treated with 200 U/ml collage-
nase IV for 5–10 min and then transferred to 6- or 12-well
ultralow attachment plates (Corning). Clumps of variable
size were incubated overnight to allow hEB formation in
hEB differentiation medium consisting of KO-DMEM supple-
mented with 20% nonheat-inactivated fetal bovine serum
(FBS; Hyclone, Logan, UT), 1% nonessential amino acids,
1 mM L-glutamine, 0.1 mM β-mercaptoethanol. For HD cul-
ture, the clumps were scraped after treatment of collage-
nase IV and transferred to 6-well low attachment plates
containing the same hEB differentiation medium overnight
and then evenly distributed on the lids of a 60-mm
polystyrene petri dish (BD Labware, NJ, USA). For hEBgeneration using single hESCs by the FA method, we adapted
the “conical tube” method performed by Kurosawa et al.
(Kurosawa et al., 2003) to obtain aggregates of single hESCs
in a polypropylene 1.5-ml conical tube (Sarstedt Inc.,
Montreal, QC, Canada). The confluent undifferentiated
hESCs were dissociated into single cell suspension by TrypLE
(Invitrogen), rinsed with phosphate-buffered saline (PBS),
and resuspended in hEB differentiation medium. The single
cell suspension was filtered with a 70-µm cell strainer (BD
Biosciences) and counted. hEB formation was carried out by
placing the defined number (2–8×104 cells) of single cells
reconstituted with 1 ml hEB differentiation medium in a
polypropylene 1.5-ml conical tube with a screw cap. After
distribution, the tubes were centrifuged at 450 g for 5 min
and incubated overnight to allow hEB formation in loosely
closed caps for gas supply.
Hematopoietic differentiation in the presence and
absence of serum
In order to evaluate hematopoietic differentiation of SP-,
HD-, and FA-EBs in the presence and absence of serum, hEBs
were cultured in hEB differentiation medium containing 20%
FCS and StemPro-34 serum-free medium (Invitrogen) supple-
mented with hematopoietic growth factors (hGFs) as
previously described (Chadwick et al., 2003). Briefly,
medium was changed with the hEB differentiation and
StemPro-34 serum-free medium supplemented with hGFs
as follows: 50 ng/ml granulocyte colony stimulating factor
(G-CSF; Amgen, Inc., Thousand Oaks, CA, USA), 300 ng/ml
stem cell factor (SCF; Amgen), 10 ng/ml interleukin-3 (IL-3;
R&D systems, Minneapolis, MN, USA), 10 ng/ml interleukin-6
(IL-6; R&D systems), 25 ng/ml BMP-4 (R&D systems), and
300 ng/ml Flt-3 ligand (Flt-3 L: R&D systems). The hEBs were
cultured for 15 days where the medium including the hGFs
was changed at 3-day intervals. To examine paracrine
potential of hEBs during hematopoietic development, hEBs
cultured in groups (10 hEBs/well) were compared with hEBs
cultured alone (one hEB/well) or in conditioned medium
(CM). CM was freshly obtained by collection of medium used
to feed hEBs cultured in groups. The collected CM was
filtered prior to replacement. To rule out undesirable effect
of serum, StemPro34 serum-free medium was used.
Flow cytometry analysis
hEBs were dissociated with 0.4 U/ml collagenase B (Roche
Diagnostics, Laval, QC, Canada) for 2 h in 37 °C incubator,
followed by treatment with cell dissociation buffer (Invitro-
gen) for 10 min in a 37 °C waterbath and then passed through
a 40-µm cell strainer (BD Biosciences). Single cell suspensions
were resuspended at approximately 1 to 2×105 cells/ml
with PBS/3% FBS and stained for 1 h at 4 °C with fluoro-
chrome-conjugated monoclonal antibodies as follows: CD31-
phycoerythrin (PE) (BD Pharmingen, San Diego, CA), CD34-
fluorescein isothiocyanate (FITC) (Miltenyi Biotech, Bergisch
Gladbach, Germany), and CD45-allophycocyanin (APC) (Mil-
tenyi Biotech) or their corresponding isotype controls.
Stained cells were washed twice in PBS/3% FBS, resuspended
in PBS/3% FBS, and then stained with 7-aminoactinomycin D
(7-AAD) (Immunotech, Marseille, France) viability dye for
129Multiparameter comparisons of embryoid body differentiation toward human stem cell applications10 min at RT. Live cells were analyzed for surface marker
expression using a FACSCalibur cell analyzer (Becton Dick-
inson Immunocytometry Systems, San Jose, CA) and Cell
Quest software (BDIS).
Sorting of hEBs
To isolate CD45+CD34+, CD45+CD34-, and CD45-CD34+ cells,
hEBs were dissociated with collagenase B and stained with
CD31-PE, CD34-FITC, CD45-APC, and 7AAD. Each cellular
subset was sorted on a FACSAria (BD Pharmingen) as
previously described (Wang et al., 2004).
Clonogenic progenitor cell assay
Clonogenic progenitor assays were performed by plating single
cell suspensions of dissociated hEB into methylcellulose H4230
(StemCell Technologies, Vancouver, BC, Canada) as previously
described (Chadwick et al., 2003). Briefly, hEBs were
dissociated with collagenase B and cell dissociation buffer
and filtered through a 40-µm cell strainer. Dissociated hEBs
were counted and 15 000 cells were plated into methylcellu-
lose H4230 supplemented with recombinant human growth
factors as follows: 50 ng/ml SCF, 3 units/ml erythropoietin
(EPO; Amgen), 10 ng/ml granulocyte monocyte-colony stimu-
lating growth factor (GM-CSF; Novartis, Dorval, QC, Canada),
and 10 ng/ml IL-3. After 14 days, differential colony counts
were performed based on morphology.
Whole-mount immunological staining
hEBs cultured in hematopoietic differentiation media for
3 days were fixed using fresh methanol:DMSO (4:1) and
stored at 4 °C overnight. hEBs were then rehydrated in
methanol, washed in PBT (PBS containing 0.1% Tween 20),
and incubated with blocking solution (TBST containing 2%
nonfat milk carnation and 0.5% Tween) for 1 h. hEBs were
stained at 4 °C overnight with primary antibodies as follows:
goat polyclonal POU5F1 (1:50 dilution, Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) and goat polyclonal Sox2 (1:40
dilution, R&D systems). After washing in TBST for 5 h, hEBs
were incubated with their corresponding secondary anti-
bodies for 5 h and then washed twice in TBS. Stained hEBs
were observed under a fluorescence microscope (Nikon,
SMZ1000, Japan).
Statistical analysis
All results were expressed as means±SD and generated from
at least three independent experiments. Statistical signifi-
cance was determined using the Student t test and
differences were considered significant when Pb0.05.
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